OA03.05 A Randomized, Phase 3 Study of Iruplinalkib (WX-0593) vs Crizotinib in Locally Advanced or Metastatic ALK+ Non-small Cell Lung Cancer (NSCLC)

Y. Shi,J. Chen, R. Yang,H. Wu, Z. Wang, W. Yang, J. Cui, Y. Zhang, C. Liu,Y. Cheng,Y. Liu, J. Shan,D. Wang, L. Yang, C. Hu,J. Zhao, R. Cao, B. Tan,K. Xu, M. Si

Journal of Thoracic Oncology(2023)

引用 0|浏览2
暂无评分
关键词
lung cancer,crizotinib,iruplinalkib,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要